title: [Carcinoma-associated retinopathy: a review with clinical examples].
abstract: Cancer-associated retinopathy (CAR) is a rare paraneoplastic syndrome. In this survey we report about two further patients with CAR, who were referred to the University Eye Hospital of Tuebingen within a few months. The most common primary tumor associated with CAR is small cell carcinoma of the lung. Case reports about rhabdomyosarcoma, carcinoma of the endometrium, prostate and mamma were also described. The exact pathogenesis of CAR is still unknown. Specific autoantibodies were found against the photoreceptor protein recovering (23-kd retinal CAR antigen). However, this reaction is not present in all patients, and probably other antigens are also involved. Most of the patients experience symptoms of CAR before the primary tumor is detected. Besides glare sensitivity and flashing lights, a rapidly progressive, often asymmetric visual loss may occur. Although paracentral and mid-peripheral scotomas can be found frequently, visual field defects are often quite heterogeneous. Typically, the responses in the electroretinogram (ERG) are markedly reduced, but normal ERGs were also described. The fundus picture in CAR shows sheathing of the retinal vessels, narrowing of the arterioles and clumbing of the retinal pigment epithelium. The prognosis is poor. Frequently there is progression to bilateral loss of vision within a few months. Treatment of the primary tumor does not seem to alter the ocular prognosis. Systemic corticosteroids may be helpful in some patients. Nevertheless, no proven therapeutic regimen is currently available.
authors.affiliation: Abteilung III, Univ.-Augenklinik Tübingen.
authors.forename: B
authors.initials: B
authors.lastname: Sobottka
authors.forename: T
authors.initials: T
authors.lastname: Schlote
authors.forename: D
authors.initials: D
authors.lastname: Besch
authors.forename: T
authors.initials: T
authors.lastname: Djelebova
authors.forename: H
authors.initials: H
authors.lastname: Wilhelm
authors.forename: E
authors.initials: E
authors.lastname: Zrenner
mesh_terms: D000368:Aged; D001323:Autoantibodies / Q000097:blood; D001943:Breast Neoplasms / Q000175:diagnosis / Q000276:immunology; D002135:Calcium-Binding Proteins / Q000276:immunology; D002277:Carcinoma / Q000175:diagnosis / Q000276:immunology; D003937:Diagnosis, Differential; D004596:Electroretinography; D005136:Eye Proteins; D005260:Female; D051597:Hippocalcin; D006801:Humans; D008074:Lipoproteins; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins; D009902:Optic Neuritis / Q000175:diagnosis / Q000276:immunology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis* / Q000276:immunology; D051603:Recoverin; D012164:Retinal Diseases / Q000175:diagnosis* / Q000276:immunology; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000276:immunology
chemical_list: D001323:Autoantibodies; D002135:Calcium-Binding Proteins; D005136:Eye Proteins; D008074:Lipoproteins; D009419:Nerve Tissue Proteins; C496731:RCVRN protein, human; D051603:Recoverin; D051597:Hippocalcin